Lataa...
SGLT2 inhibitors and the changing landscape for treatment of diabetes
Type 2 diabetes mellitus has become an epidemic with rapidly increasing prevalence worldwide. While strict glycemic control has been shown to reduce the risk of diabetic microvascular complications, its role in preventing cardiovascular disease has been less clear. Indeed, anti-hyperglycemic therapi...
Tallennettuna:
| Julkaisussa: | Ther Clin Risk Manag |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628608/ https://ncbi.nlm.nih.gov/pubmed/31371973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S207515 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|